Peer-reviewedCC BYFrontiers in pharmacology
Cannabinoids in oncology: pharmacology, clinical applications, and translational perspectives
- 1University of New England College of Osteopathic Medicine , , ,
- 2Division of Hematology and Oncology, The Miriam Hospital, Warren Alpert Medical School of Brown University , , ,
Related
- Phytochemical basis, multitarget pharmacology, and translational perspectives of silymarin: emphasis on its antifibrotic effects
- Stem Cell-Based Therapies in Companion Animals: Molecular Mechanisms, Clinical Applications, and Translational Perspectives
- Mitochondrial metabolic plasticity in cancer: hybrid bioenergetic states and translational targeting in surgical oncology
- Curcumin pharmacology and pharmacokinetics: current challenges and future perspectives in nanoemulsion delivery
- Ensemble signal detection reveals target-specific temporal risk of hypokalemia after immune checkpoint inhibition: a translational pharmacology framework
BibTeX
@article{safran2026cannabinoids,
title = {{Cannabinoids in oncology: pharmacology, clinical applications, and translational perspectives}},
author = {Emma Safran and Howard Safran and Stanley Kim},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13658078},
note = {CC BY},
}
RIS
TY - JOUR
TI - Cannabinoids in oncology: pharmacology, clinical applications, and translational perspectives
AU - Emma Safran
AU - Howard Safran
AU - Stanley Kim
PY - 2026
DA - 2026/10/16
JO - Frontiers in pharmacology
UR - https://europepmc.org/article/PMC/PMC13658078
SN - 1663-9812
ER -